EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische Studie

Beta-Blocker Interruption or Continuation after Myocardial Infarction

Johanne Silvain iD, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, Paul Guedeney, Thomas Cuisset, Fabrice Ivanes, Thibault Lhermusier, Thibault Petroni, Gilles Lemesle und 25 weitere

New England Journal of Medicine · 10.10.2024 · 391 (14) · 1277-1286

DOI: 10.1056/nejmoa2404204 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von Johanne Silvain und 36 weiteren Autor:innen. Beteiligte Einrichtung: From Sorbonne Université, ACTION Group, INSERM Unité Mixte de Recherche (UMRS) 1166, Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris …. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Myocardial Infarction, Quality of Life, Secondary Prevention. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Ministère de la Santé, French Ministry of Health, ACTION.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsMyocardial InfarctionQuality of LifeSecondary PreventionAgedFemaleHumansMaleMiddle AgedDrug Administration ScheduleFollow-Up StudiesHospitalizationKaplan-Meier EstimateStroke VolumeWithholding Treatment

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • From Sorbonne Université, ACTION Group, INSERM Unité Mixte de Recherche (UMRS) 1166, Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris (AP-HP) (J.S., P.G., N.P., K.A., G.M.), the Department of Cardiology,…

ORCID-Profile: Johanne Silvain, Christophe Thuaire, Pierre Deharo

Förderung

  • Ministère de la Santé
  • French Ministry of Health
  • ACTION

Zitieren

APA

Silvain, J., Cayla, G., Ferrari, E., Range, G., Puymirat, E., Delarche, N., Guedeney, P., Cuisset, T., Ivanes, F., Lhermusier, T., Petroni, T., Lemesle, G., Bresoles, F., Labeque, J. N., Pommier, T., Dillinger, J. G., Leclercq, F., Boccara, F., Lim, P., …, & ABYSS Investigators of the ACTION Study Group (2024). Beta-Blocker Interruption or Continuation after Myocardial Infarction. New England Journal of Medicine, 391(14), 1277-1286. https://doi.org/10.1056/nejmoa2404204

Vancouver

Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, et al. Beta-Blocker Interruption or Continuation after Myocardial Infarction. New England Journal of Medicine. 2024;391(14):1277-1286. doi:10.1056/nejmoa2404204

BibTeX
@article{Silvain2024,
  author = {Silvain, Johanne and Cayla, Guillaume and Ferrari, Emile and Range, Grégoire and Puymirat, Etienne and Delarche, Nicolas and Guedeney, Paul and Cuisset, Thomas and Ivanes, Fabrice and Lhermusier, Thibault and Petroni, Thibault and Lemesle, Gilles and Bresoles, François and Labeque, Jean-Noël and Pommier, Thibaut and Dillinger, Jean-Guillaume and Leclercq, Florence and Boccara, Franck and Lim, Pascal and Besseyre des Horts, Timothée and Fourme, Thierry and Jourda, François and Furber, Alain and Lattuca, Benoit and Redjimi, Nassim and Thuaire, Christophe and Deharo, Pierre and Procopi, Niki and Dumaine, Raphaelle and Slama, Michel and Payot, Laurent and El Kasty, Mohamad and Aacha, Karim and Diallo, Abdourahmane and Vicaut, Eric and Montalescot, Gilles and ABYSS Investigators of the ACTION Study Group, ABYSS Investigators of the ACTION Study Group},
  title = {Beta-Blocker Interruption or Continuation after Myocardial Infarction},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {14},
  pages = {1277--1286},
  doi = {10.1056/nejmoa2404204}
}
Kostenlos starten →